01-27-2020 09:27 AM CET | Health & Medicine | Press release from: P&S Intelligence The key reasons behind the advance of the digital health market are the widening applications of mobile health (mHealth), rising adoption of smartphones and tablets, and increasing government support for such solutions. From its value of $73.1 billion in 2017, the [...]
By Timothy M. Smith | Senior News Writer | American Medical Association | JANUARY 27, 2020 Augmented intelligence (AI) promises to be a transformational force in health care, especially within primary care. Experts outline ways that innovations driven by AI—often called artificial intelligence—can aid rather than subvert the patient-physician relationship. “AI implemented poorly risks pushing [...]
Posted on January 21, 2020 by Mehedi Hassan | Thurott.com Google launched an interesting new project last year called Digital Health Experiments. The project included interesting Digital Health apps that are meant to help you use your phone less, and focus on the real-world more. At the time, Google launched 5 apps in total under the Digital Health Experiments project. [...]
By ELISE REUTER | MedCityNews | Jan 21, 2020 at 6:45 PM Digital health companies faced bad news going into 2020, from job cuts to dissolving pharma partnerships. But these struggles are part of an industry that is finding its identity in a crowded healthcare market. As the digital health industry gains ground, companies have bandied [...]
By Dave Muoio | January 16, 2020 | MobiHealthNews More often than not, survey respondents said that patient data collected using apps, wearables or other consumer-friendly sources are clinically valuable. Data and digital health tech were the focus of Stanford Medicine’s 2020 Health Trends Report. Released late last week, the research survey of more than 700 [...]
By Greg Licholai | Forbes.com | Jan 14, 2020, 09:44am It has been an extraordinary time for digital medicine and the new year will bring continued growth. The key drivers are expanded patient engagement as well as institutional investment with the ultimate goal of reducing costs. Big pharma, payers and insurance companies have recognized the [...]
